Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.

Core needle biopsy (CNB) is used to sample both mammographically and ultrasound detected breast lesions. A diagnosis of ductal carcinoma in situ (DCIS) by CNB does not ensure the absence of invasive cancer upon surgical excision and as a result an upstaged patient may need to undergo additional surg...

Descripción completa

Detalles Bibliográficos
Publicado en:Breast Journal Vol. 13; no. 3; pp. 251 - 258
Autores principales: Rutstein LA, Johnson RR, Poller WR, Dabbs D, Groblewski J, Rakitt T, Tsung A, Kirchner T, Sumkin J, Keenan D, Soran A, Ahrendt G, Falk JS
Formato: research Journal Article
Publicado: Wiley-Blackwell May/Jun2007
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105731123&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105731123
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1075122X
        ET6
      jtl: Breast Journal
      issn: 1075122X
      maglogo: Y
    pubinfo:
      dt: May/Jun2007
      vid: 13
      iid: 3
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        105731123
        105731123
        2009630197
        10.1111/j.1524-4741.2007.00418.x
        NLM17461899
        105731123
      ppf: 251
      ppct: 7
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
      aug:
        au:
          Rutstein LA
          Johnson RR
          Poller WR
          Dabbs D
          Groblewski J
          Rakitt T
          Tsung A
          Kirchner T
          Sumkin J
          Keenan D
          Soran A
          Ahrendt G
          Falk JS
        affil: Maine Medical Center, Portland, Maine 04102, USA.
      sug:
        subj:
          Adenocarcinoma Pathology
          Adenocarcinoma
          Biopsy, Needle
          Breast Neoplasms Pathology
          Precancerous Conditions Pathology
          Adult
          Aged
          Female
          Middle Age
          Neoplasm Invasiveness
          Neoplasm Metastasis
          Neoplastic Processes
          Physical Examination
          Predictive Value of Tests
          Prospective Studies
          Retrospective Design
          Human
          Adult: 19-44 years
          Aged: 65+ years
          Middle Aged: 45-64 years
          Female
      ab: Core needle biopsy (CNB) is used to sample both mammographically and ultrasound detected breast lesions. A diagnosis of ductal carcinoma in situ (DCIS) by CNB does not ensure the absence of invasive cancer upon surgical excision and as a result an upstaged patient may need to undergo additional surgery for axillary nodal evaluation. This study evaluates the accuracy of CNB in excluding invasive disease and the preoperative features that predict upstaging of DCIS to invasive breast cancer. Two hundred fifty-four patients over an 8-year period from 1994 to 2002 with a diagnosis of DCIS alone by CNB were retrospectively reviewed. Underestimation of invasive cancer by CNB was determined. Radiographic, pathologic, and surgical features of the cohort were compared using univariate and multivariate analysis. The mean age was 55 years (range 27-84) and mean follow-up was 25 months with one patient unavailable for follow-up. There were a total of six patient deaths, all of which were not disease-specific. A total of 21 out of 254 patients (8%) with DCIS by CNB were upstaged to invasive cancer following surgical excision. There was a significant inverse relationship between the number of core biopsies and the incidence of upstaging (p < 0.006) in that patients with fewer core samples were more likely to be upstaged at surgical pathology. No relationship was noted between the size of the core samples and the likelihood of upstaging (p > 0.4). Of 21 patients with invasion, all but two had comedonecrosis by CNB. Comedonecrosis by CNB significantly increased the likelihood of upstaging (p < 0.001). Of the 21 patients who were upstaged, 12 required subsequent surgery for nodal evaluation while nine had sentinel node biopsy at initial operation. Finally, upstaged patients were significantly more likely to have a positive margin (p < 0.008). Ductal carcinoma in situ with comedonecrosis on CNB can help to predict the possibility of invasion. Increasing the number of core biopsies reduced the likelihood of sampling error.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N